Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK051362-28
Regulation of Mucosal Lymphocytes
Recipient
Brigham and Women's Hospital
Award Amount
$712,142.00
Ceiling
$712,142.00
Awarded
March 20, 2026
Identifier
5R01DK051362-28
This NIH-funded project studies how CEACAM1 protein regulates antimicrobial peptides in the gut to protect against bacteria and inflammatory bowel disease, with potential therapeutic applications.
Description
The research focuses on the role of CEACAM1 in regulating antimicrobial peptide production in intestinal epithelial cells, aiming to understand its potential in protecting against intestinal bacteria and inflammatory bowel disease.